Samuel D. Jordan

A randomised, prospective, phase III clinical trial of primary bleomycin, ifosfamide and cisplatin (BIP) chemotherapy followed by radiotherapy versus radiotherapy alone in inoperable cancer of the cervix

J. Herod, Andrea Burton, John Buxton et al. · Annals of Oncology · 2000 · 42 citations · Full text

Medicine, Oncology, Radiation Oncology +12

A Randomised Controlled Trial to Evaluate both the Role and the Optimal Fractionation of Radiotherapy in the Conservative Management of Early Breast Cancer

D. Spooner, Deborah Stocken, Samuel D. Jordan et al. · Clinical Oncology · 2012 · 29 citations

Medicine, Oncology, Radiation Oncology +15

Adjuvant epirubicin followed by cyclophosphamide, methotrexate and fluorouracil (CMF) vs CMF in early breast cancer: results with over 7 years median follow-up from the randomised phase III NEAT/BR9601 trials

Helena Earl, Louise Hiller, Janet Dunn et al. · British Journal of Cancer · 2012 · 18 citations · Full text

Medicine, Oncology, Pharmacology +13

Chromosome 17 polysomy (Ch17) as a predictor of anthracycline response: emerging evidence from the UK <i>NEAT</i> adjuvant breast cancer trial.

John M.S. Bartlett, Alison F. Munro, Janet Dunn et al. · Cancer Research · 2009 · 13 citations

Medicine, Cancer Biology, Oncology +17

Engineered tissue geometry and Plakophilin-2 regulate electrophysiology of human iPSC-derived cardiomyocytes

Daniel W. Simmons, Ganesh Malayath, David Schuftan et al. · APL Bioengineering · 2024 · 13 citations · Full text

Engineering, Bioengineering, Physiology +17